Skip to main content
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1979 Feb;72(2):134–135. doi: 10.1177/014107687907200212

Oral herpes simplex virus infection. Treatment.

J B Kurtz
PMCID: PMC1436775  PMID: 552476

Full text

PDF
134

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen L. B., Hintz O. J., Wolf S. M., Huffman J. H., Simon L. N., Robins R. K., Sidwell R. W. Effect of 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate on genital lesions and encephalitis induced by Herpesvirus hominis type 2 in female mice. J Infect Dis. 1976 Jun;133 (Suppl):A178–A183. doi: 10.1093/infdis/133.supplement_2.a178. [DOI] [PubMed] [Google Scholar]
  2. Ch'ien L. T., Whitley R. J., Alford C. A., Jr, Galasso G. J. Adenine arabinoside for therapy of herpes zoster in immunosuppressed patients: preliminary results of a collaborative study. J Infect Dis. 1976 Jun;133 (Suppl):A184–A191. doi: 10.1093/infdis/133.supplement_2.a184. [DOI] [PubMed] [Google Scholar]
  3. Juel-Jensen B. Effects of cytarabine on virus shedding in herpes simplex virus infections. J Antimicrob Chemother. 1977 Mar;3 (Suppl A):125–129. doi: 10.1093/jac/3.suppl_a.125. [DOI] [PubMed] [Google Scholar]
  4. KAUFMAN H. E., MALONEY E. D. IDU and cytosine arabinoside in experimental herpetic keratitis. Arch Ophthalmol. 1963 May;69:626–629. doi: 10.1001/archopht.1963.00960040632017. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES